United States:
Health Law Diagnosed — Hot Topics In FDA Regulation And Enforcement
To print this article, all you need is to be registered or login on Mondaq.com.
This past year has been a busy one for the FDA, but it
hasn't all been about the pandemic. FDA attorneys Joanne Hawana and Benjamin Zegarelli discuss the
agency's ongoing efforts to protect the public from unproven
COVID-19 cures while also pushing forward with its most important
regulatory priorities, such as digital health, cannabis-derived
compounds, and laboratory-developed tests and other diagnostic
products.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
Healthcare Policy Developments To Watch In 2024
Crowell & Moring LLP
The ever-changing healthcare policy landscape will witness at the federal level regulatory changes driven by the need to transform healthcare delivery, quality and innovation.
The FDA And The Future Of AI Oversight
Manatt, Phelps & Phillips LLP
In January 2024, the U.S. Government Accountability Office (GAO) issued a report highlighting current obstacles to the U.S. Food and Drug Administration's (FDA) timely and effective regulation...